A systematic, company-by-company intelligence report covering the world's ten leading biotechnology companies — Alnylam Pharmaceuticals, Amgen, Biogen, CSL, Gilead Sciences, Novo Nordisk, Regeneron, Takeda, Teva Pharmaceutical, and Vertex Pharmaceuticals — with identical analytical depth across each company covering strategic directions, financial performance, SWOT analysis, technological know-how, latest products and pipeline, M&A activity, marketing tactics, and organization and management.
The competitive landscape of biotechnology is being reshaped by the extraordinary commercial success of GLP-1 receptor agonists — Novo Nordisk's Wegovy and Ozempic generated over $20 billion in combined 2025 sales and created the largest new drug market in history — alongside the maturation of biosimilar competition threatening legacy biologics franchises, the emergence of RNA-based therapeutics as a new modality, and the commercial validation of cell and gene therapy in rare disease. Amgen's $28 billion acquisition of Horizon Therapeutics has transformed its rare disease portfolio. Regeneron's Dupixent — the world's best-selling immunology drug — continues to gain approvals across new indications.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Table of Contents
1. Executive Summary
2. Competitive Landscape Overview
3. Alnylam Pharmaceuticals
4. Amgen
5. Biogen
6. CSL
7. Gilead Sciences
8. Novo Nordisk
9. Regeneron
10. Takeda
11. Teva Pharmaceutical
12. Vertex Pharmaceuticals
13. Comparative Analysis
14. Appendix
List of Tables
Table 1. World's Leading Companies — Key Financial Metrics 2023-2025
Table 2. World's Leading Companies — Revenue by Therapeutic Area 2025
Table 3. World's Leading Companies — Revenue by Geography 2025
Table 4. World's Leading Companies — R&D Investment 2023-2025
Table 5. World's Leading Companies — SWOT Summary
Table 6. World's Leading Companies — Key Products and Pipeline 2025
Table 7. World's Leading Companies — M&A Activity 2023-2025
Table 8. World's Leading Companies — Key Management 2025
Table 9. World's Leading Companies — Strategic Priorities 2025-2030
Companies Profiled
Amgen
AstraZeneca
Biogen
Bristol-Myers Squibb
CSL Behring
Gilead Sciences
Moderna
Regeneron
Roche
Vertex Pharmaceuticals
